Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 226 AL 240

Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis

Carmona-Iragui M, Videla L, Lleó A, Fortea J.

Dev Neurobiol. 2019 Jul;79(7):716-737. doi: 10.1002/dneu.22709. Epub 2019 Aug 5.

Can Adults with Mild Cognitive Impairment Build Cognitive Reserve and Learn Mindfulness Meditation? Qualitative Theme Analyses from a Small Pilot Study

Wells RE, Kerr C, Dossett ML, Danhauer SC, Sohl SJ, Sachs BC, Feeley JW, Wolkin J, Wall R, Kaptchuk T, Press DZ, Phillips RS, Yeh GY.

J Alzheimers Dis. 2019;70(3):825-842. doi: 10.3233/JAD-190191.

When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram

Aga VM.

Am J Geriatr Psychiatry. 2019 Oct;27(10):1099-1107. doi: 10.1016/j.jagp.2019.04.016. Epub 2019 May 10.

Adjusted mortality rates attributable to Alzheimer's disease dementia, Brazil, 2009-2013

Sandoval JJ, Turra CM, Loschi RH.

Cad Saude Publica. 2019 Jul 4;35(6):e00091918. doi: 10.1590/0102-311X00091918.

High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer's disease

Zhang F, Qin Y, Xie L, Zheng C, Huang X, Zhang M.

J Neural Transm (Vienna). 2019 Aug;126(8):1081-1094. doi: 10.1007/s00702-019-02022-y. Epub 2019 Jul 10.

Review of AAC interventions in persons with dementia

May AA, Dada S, Murray J.

Int J Lang Commun Disord. 2019 Nov;54(6):857-874. doi: 10.1111/1460-6984.12491. Epub 2019 Jul 19.

Longitudinal progression of posterior cortical atrophy over 11 years: Relationship between lesion topology and clinical deficits

Kujovic M, Malikovic A, Jochum S, Margittai Z, Lange-Asschenfeldt C, Supprian T.

J Clin Exp Neuropsychol. 2019 Oct;41(8):875-880. doi: 10.1080/13803395.2019.1638345. Epub 2019 Jul 19.

Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure

Mattos MK, Sereika SM, Beach SR, Kim H, Klunk WE, Knox M, Nadkarni NK, Parker LS, Roberts JS, Schulz R, Tamres L, Lingler JH.

J Alzheimers Dis. 2019;71(4):1071-1079. doi: 10.3233/JAD-190091.

Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria

Triviño-Ibáñez EM, Sánchez-Vañó R, Sopena-Novales P, Romero-Fábrega JC, Rodríguez-Fernández A, Carnero Pardo C, Martínez Lozano MD, Gómez-Río M.

Medicine (Baltimore). 2019 Jul;98(29):e16509. doi: 10.1097/MD.0000000000016509.

Sleep and Memory: The Promise of Precision Medicine

Carter P, Ye L, Richards K, Vallabhaneni V.

Sleep Med Clin. 2019 Sep;14(3):371-378. doi: 10.1016/j.jsmc.2019.05.001. Epub 2019 Jun 8.

Does the Right Focal Variant of Alzheimer's Disease Really Exist? A Literature Analysis

Abbate C, Trimarchi PD, Inglese S, Damanti S, Dolci GAM, Ciccone S, Rossi PD, Mari D, Arosio B, Bagarolo R, Giunco F, Cesari M.

J Alzheimers Dis. 2019;71(2):405-420. doi: 10.3233/JAD-190338.

Validity of the French Prospective and Retrospective Memory Questionnaire (PRMQ) in healthy controls and in patients with no cognitive impairment, mild cognitive impairment and Alzheimer disease

Guerdoux-Ninot E, Martin S, Jailliard A, Brouillet D, Trouillet R.

J Clin Exp Neuropsychol. 2019 Nov;41(9):888-904. doi: 10.1080/13803395.2019.1625870. Epub 2019 Aug 6.

Glucose dysregulation in pre-clinical Alzheimer's disease

Connolly NMC, Theurey P, Pizzo P.

Aging (Albany NY). 2019 Aug 4;11(15):5296-5297. doi: 10.18632/aging.102146. Epub 2019 Aug 4.

Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease

Boche D, Gerhard A, Rodriguez-Vieitez E; MINC Faculty.

Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2831-2847. doi: 10.1007/s00259-019-04462-w. Epub 2019 Aug 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias